LIR Life Sciences Corp. (CSE:SKNY)
Canada
· Delayed Price · Currency is CAD 1.370
+0.180 (15.13%)
At close: Dec 5, 2025
LIR Life Sciences Company Description
LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada.
LIR Life Sciences Corp.
| Country | Canada |
| Founded | 2024 |
| Industry | Pharmaceutical Preparations |
| CEO | Edward Mills |
Contact Details
Address: 1505 W 2nd Ave Vancouver, British Columbia V6J 1H2 Canada | |
| Phone | (888) 436 7772 |
| Website | lirlifesciences.com |
Stock Details
| Ticker Symbol | SKNY |
| Exchange | Canadian Securities Exchange |
| Reporting Currency | CAD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Edward Mills | Chief Executive Officer |
| Harpreet Nijjar | Chief Financial Officer |